Eli Lilly And reported $5.06B in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6324M 584M
Amgen AMGN:US $ 5084M 407M
AstraZeneca AZN:LN 728.3B 34.55B
Astrazeneca AZN:US 8.87B 244M
Baxter International BAX:US $ 1457M 107M
Biogen BIIB:US $ 2105.1M 327.2M
Bristol Myers Squibb BMY:US $ 9210M 33M
Catalent CTLT:US $ 488M 65M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Gilead Sciences GILD:US $ 4818M 348M
GlaxoSmithKline GSK:LN 479.3B 29.3B
Glaxosmithkline GSK:US $ 4793M 1342M
Horizon Pharma HZNP:US $ 646.2M 23.99M
Intercept Pharmaceuticals ICPT:US $ 71.45M 16.38M
JAZZ PHA JAZZ:US $ 808.67M 110.23M
Johnson & Johnson JNJ:US $ 16101M 273M
Lannett LCI:US $ 7.86M 4.78M
Medtronic MDT:US $ 4904M 620M
Merk MRK:US $ 10895M 328M
Neurocrine Biosciences NBIX:US $ 373.4M 67.4M
Novartis NVS:US $ 9336M 277M
Novartis NOVN:VX 9.34B 277M
Perrigo Ordinary Shares PRGO:US $ 372.1M 34.3M
Pfizer PFE:US $ 19071M 3420M
Prestige Brands PBH:US $ 160.12M 11.26M
Regeneron Pharmaceuticals REGN:US $ 2560.1M 0.1M
Revance Therapeutics RVNC:US $ 18.84M 1.48M
Teva Pharmaceutical Industries TEVA:US $ 1828M 26M
United Therapeutics UTHR:US $ 437.2M 1.2M
Zoetis ZTS:US $ 1432M 11M